Drug Intelligence Bulletin by Keith Graves

Graves and Associates Sep 30, 2021

Marijuana Legalization Increases Juvenile Medical Emergencies

Emergency department pediatric visits in Alberta for Marijuana after legalization A study by a different group of…

Read article →
Graves and Associates Sep 30, 2021

Study: Marijuana Does not Prevent Opioid Overdoses

Researchers from Columbia University and the New York State Psychiatric Institute used data from two sources to learn…

Read article →
Graves and Associates Sep 27, 2021

Fentanyl and Analog Dosage Guide

What is a dose of fentanyl? It’s an important question for criminal justice professionals to know. Knowing what a dose…

Read article →
Graves and Associates Sep 27, 2021

DEA Issues Warning on Fake Prescription Pills

Fentanyl is often pressed into pills that look exactly like legitimate prescription medication like Xanax, Morphine…

Read article →
Graves and Associates Sep 24, 2021

Metodesnitazene: A New Opiate in the Illicit Drug Scene

What is Metodesnitazene? NPS Discovery recently announced the discovery of a novel psychoactive substance (NPS) called…

Read article →
Graves and Associates Sep 10, 2021

Is Smoking Fentanyl the Latest Trend?

A collaborative study just published in Drug and Alcohol Dependence led by Alex Kral at RTI found that there was a shift…

Read article →
Graves and Associates May 20, 2021

Phenacetin is a Toxic Cutting Agent Found in Cocaine and Fentanyl

Recently, a public health alert was published by NPSDiscovery.org on a new toxic cutting agent, Phenacetin. According to…

Read article →
Graves and Associates May 19, 2021

N-Methyl-2-Aminoindane (NM-2-AI) is The Latest Drug to Come to Market

On average, one new synthetic drug comes to the black market. These drugs are often referred to as Novel Psychoactive…

Read article →